Clinical Trial

Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients

Study acronym: OCARE-MM
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial aims to assess the effectiveness of a mobile application-based education program, developed according to Orem's Self-Care Model, in improving self-care agency and quality of life among patients with multiple myeloma in Turkey. Participants are recruited from the outpatient clinic of a hospital and randomly assigned to either the intervention or control group. The intervention group uses the mobile application for 24 weeks, while the control group continues with routine care and receives a standard one-page brochure commonly distributed to cancer patients. All participants complete a demographic form, the EORTC QLQ-C30, QLQ-MY20, and the Self-Care Agency Scale at baseline, week 12, and week 24. The collected data will be used to compare changes in self-care agency and quality of life between the two groups over time.
Trial Details
NCT Number NCT07088783
Lead Sponsor Ozlem
Collaborators: Dokuz Eylul University
Conditions Multiple Myeloma (MM), Self-care, Quality of Life
Enrollment 60 participants
Start Date 2024-06-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-28